Efalizumab
Product Specifications
CAS Number
214745-43-4
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Purity
0.9877
Bioactivity
Efalizumab, a novel potent regulator of T cells, is a humanized LFA-1 α subunit (CD11a) monoclonal antibody. Efalizumab has inhibitory effects on T cell activation, skin T cell transport, and T cell adhesion to keratinocytes, and can be used to study plaque psoriasis and psoriatic arthritis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1483963-01 0.02 mg (E-Coli)
Recombinant Pseudomonas syringae pv. phaseolicola N-succinylarginine dihydrolase (astB)
Sign In for Pricing
View Details MBS1483963-02 0.02 mg (Yeast)
Recombinant Pseudomonas syringae pv. phaseolicola N-succinylarginine dihydrolase (astB)
Sign In for Pricing
View Details MBS1483963-03 0.1 mg (E-Coli)
Recombinant Pseudomonas syringae pv. phaseolicola N-succinylarginine dihydrolase (astB)
Sign In for Pricing
View Details MBS1483963-04 0.1 mg (Yeast)
Recombinant Pseudomonas syringae pv. phaseolicola N-succinylarginine dihydrolase (astB)
Sign In for Pricing
View Details MBS1483963-05 0.02 mg (Baculovirus)
Recombinant Pseudomonas syringae pv. phaseolicola N-succinylarginine dihydrolase (astB)
Sign In for Pricing
View Details MBS1483963-06 0.02 mg (Mammalian-Cell)
Recombinant Pseudomonas syringae pv. phaseolicola N-succinylarginine dihydrolase (astB)
Sign In for Pricing
View Details